Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Pharmaceutical Statistics|November 2, 2022
On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomesMickaël De Backer, Catherine Legrand, Julien Péron, et al.Journal of Clinical Epidemiology|April 3, 2024
Restricted Net Treatment Benefit in oncologyMax Piffoux, Brice Ozenne, Mickaël De Backer, et al.Journal of the American College of Cardiology|September 20, 2023
Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the WeekJohan Verbeeck, Mickaël De Backer, Jan Verwerft, et al.Biometrical Journal. Biometrische Zeitschrift|September 17, 2020
A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisonsEva Cantagallo, Mickaël De Backer, Michal Kicinski, et al.Journal of Clinical Epidemiology|March 28, 2021
The Net Benefit of a treatment should take the correlation between benefits and harms into accountMarc Buyse, Everardo D Saad, Julien Peron, et al.Orphanet Journal of Rare Diseases|October 12, 2023
Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scoresVaiva Deltuvaite-Thomas, Mickaël De Backer, Samantha Parker, et al.Clinical Trials (London, England)|October 25, 2023
Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimenMickaël De Backer, Manju Sengar, Vikram Mathews, et al.Advances in Radiation Oncology|December 16, 2024
Benefit of Avasopasem Manganese on Severe Oral Mucositis in Head and Neck Cancer in the ROMAN Trial: Unplanned Secondary AnalysisCarryn Anderson, Samuel Salvaggio, Mickaël De Backer, et al.Pageof 1